

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.14531250 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14531250 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89613207 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77324955 |
| 5 | positive regulation of B cell differentiation (GO:0045579) | 4.29747989 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21716423 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21716423 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.21716423 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21716423 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.21716423 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21716423 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.21460561 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.16218925 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.99725791 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80834287 |
| 16 | glycolipid catabolic process (GO:0019377) | 3.79472453 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77421363 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.70678238 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.58171838 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57049293 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55476480 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.51366821 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.48475243 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.43880329 |
| 25 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.40760605 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.38963486 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33989656 |
| 28 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.32527318 |
| 29 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30505292 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.29274877 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.25619170 |
| 32 | positive regulation of interferon-alpha production (GO:0032727) | 3.20601399 |
| 33 | ceramide catabolic process (GO:0046514) | 3.20270917 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.17612786 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.10785549 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 3.10452610 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09437411 |
| 38 | response to thyroid hormone (GO:0097066) | 3.09014782 |
| 39 | respiratory burst (GO:0045730) | 3.08131382 |
| 40 | protein localization to endosome (GO:0036010) | 3.07429965 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 3.01565617 |
| 42 | amino sugar catabolic process (GO:0046348) | 2.99428084 |
| 43 | barbed-end actin filament capping (GO:0051016) | 2.98122108 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97028871 |
| 45 | mannose metabolic process (GO:0006013) | 2.96664016 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 2.96596573 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 2.92727367 |
| 48 | cellular extravasation (GO:0045123) | 2.92034487 |
| 49 | pinocytosis (GO:0006907) | 2.89829449 |
| 50 | regulation of vitamin metabolic process (GO:0030656) | 2.89236238 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89221936 |
| 52 | negative regulation of granulocyte differentiation (GO:0030853) | 2.88690266 |
| 53 | adhesion of symbiont to host (GO:0044406) | 2.87804192 |
| 54 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87434920 |
| 55 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.86169091 |
| 56 | B cell mediated immunity (GO:0019724) | 2.83097290 |
| 57 | * fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82844201 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81912671 |
| 59 | response to host immune response (GO:0052572) | 2.78509139 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78509139 |
| 61 | membrane lipid catabolic process (GO:0046466) | 2.78150829 |
| 62 | regulation of cholesterol storage (GO:0010885) | 2.77739853 |
| 63 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.76901192 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76688287 |
| 65 | sphingolipid catabolic process (GO:0030149) | 2.75961350 |
| 66 | phospholipid efflux (GO:0033700) | 2.75116203 |
| 67 | response to peptidoglycan (GO:0032494) | 2.75044536 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 2.74647872 |
| 69 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.74590594 |
| 70 | cellular response to zinc ion (GO:0071294) | 2.74466258 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74426256 |
| 72 | germinal center formation (GO:0002467) | 2.74325667 |
| 73 | regulation of mast cell degranulation (GO:0043304) | 2.73384490 |
| 74 | detection of other organism (GO:0098543) | 2.73178494 |
| 75 | adhesion of symbiont to host cell (GO:0044650) | 2.72440612 |
| 76 | virion attachment to host cell (GO:0019062) | 2.72440612 |
| 77 | response to type I interferon (GO:0034340) | 2.70420984 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 2.70127659 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68528063 |
| 80 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68157687 |
| 81 | response to laminar fluid shear stress (GO:0034616) | 2.67094960 |
| 82 | N-acetylneuraminate metabolic process (GO:0006054) | 2.66712407 |
| 83 | defense response to protozoan (GO:0042832) | 2.66342550 |
| 84 | type I interferon signaling pathway (GO:0060337) | 2.65697345 |
| 85 | cellular response to type I interferon (GO:0071357) | 2.65697345 |
| 86 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65253162 |
| 87 | detection of external biotic stimulus (GO:0098581) | 2.65075286 |
| 88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64526158 |
| 89 | regulation of podosome assembly (GO:0071801) | 2.63986807 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.63333997 |
| 91 | regulation of triglyceride catabolic process (GO:0010896) | 2.62888016 |
| 92 | response to fungus (GO:0009620) | 2.62037928 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.61831269 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.61831269 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60396261 |
| 96 | response to host (GO:0075136) | 2.60396261 |
| 97 | response to host defenses (GO:0052200) | 2.60396261 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 2.60283613 |
| 99 | regulation of superoxide anion generation (GO:0032928) | 2.60124841 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.59514924 |
| 101 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.59063164 |
| 102 | amyloid precursor protein catabolic process (GO:0042987) | 2.58484308 |
| 103 | modulation by symbiont of host cellular process (GO:0044068) | 2.58175285 |
| 104 | detection of bacterium (GO:0016045) | 2.57447402 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56949304 |
| 106 | T-helper 1 type immune response (GO:0042088) | 2.56609298 |
| 107 | regulation of chemokine biosynthetic process (GO:0045073) | 2.55394110 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.53930227 |
| 109 | regulation of mononuclear cell migration (GO:0071675) | 2.53006727 |
| 110 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52616836 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52467989 |
| 112 | leukocyte aggregation (GO:0070486) | 2.49763507 |
| 113 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49101799 |
| 114 | glucose 6-phosphate metabolic process (GO:0051156) | 2.48745939 |
| 115 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.48486608 |
| 116 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.48486608 |
| 117 | defense response to fungus (GO:0050832) | 2.48296247 |
| 118 | neutrophil activation (GO:0042119) | 2.48163023 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.46913682 |
| 120 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.45955444 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.45627607 |
| 122 | response to protozoan (GO:0001562) | 2.45457141 |
| 123 | mature B cell differentiation involved in immune response (GO:0002313) | 2.45304731 |
| 124 | positive regulation of leukocyte degranulation (GO:0043302) | 2.45109329 |
| 125 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45021377 |
| 126 | negative regulation of cell killing (GO:0031342) | 2.45021377 |
| 127 | mature B cell differentiation (GO:0002335) | 2.44311028 |
| 128 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.43990470 |
| 129 | peptide catabolic process (GO:0043171) | 2.43844242 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.43739907 |
| 131 | positive regulation of histone deacetylation (GO:0031065) | 2.43630764 |
| 132 | plasma lipoprotein particle assembly (GO:0034377) | 2.43417835 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.42697483 |
| 134 | granulocyte activation (GO:0036230) | 2.42339112 |
| 135 | neutrophil mediated immunity (GO:0002446) | 2.42271493 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42117293 |
| 137 | angiotensin maturation (GO:0002003) | 2.41616821 |
| 138 | positive thymic T cell selection (GO:0045059) | 2.41325063 |
| 139 | positive regulation of type 2 immune response (GO:0002830) | 2.40743125 |
| 140 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.39678685 |
| 141 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.39149116 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39030427 |
| 143 | tolerance induction (GO:0002507) | 2.38974969 |
| 144 | protein-lipid complex assembly (GO:0065005) | 2.38646638 |
| 145 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.38552087 |
| 146 | regulation of B cell apoptotic process (GO:0002902) | 2.37213794 |
| 147 | intestinal cholesterol absorption (GO:0030299) | 2.37010625 |
| 148 | regulation of type 2 immune response (GO:0002828) | 2.36201952 |
| 149 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.35317367 |
| 150 | plasma lipoprotein particle clearance (GO:0034381) | 2.35031386 |
| 151 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.34871004 |
| 152 | protein carboxylation (GO:0018214) | 2.34871004 |
| 153 | phospholipid homeostasis (GO:0055091) | 2.34119218 |
| 154 | stress fiber assembly (GO:0043149) | 2.33779439 |
| 155 | megakaryocyte development (GO:0035855) | 2.33462073 |
| 156 | T cell homeostasis (GO:0043029) | 2.33167874 |
| 157 | detection of biotic stimulus (GO:0009595) | 2.32952944 |
| 158 | regulation of phagocytosis (GO:0050764) | 2.32710627 |
| 159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.32566185 |
| 160 | COPI coating of Golgi vesicle (GO:0048205) | 2.32274532 |
| 161 | Golgi transport vesicle coating (GO:0048200) | 2.32274532 |
| 162 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.31820989 |
| 163 | regulation of extracellular matrix disassembly (GO:0010715) | 2.31568308 |
| 164 | positive regulation of cholesterol efflux (GO:0010875) | 2.30961594 |
| 165 | macrophage activation (GO:0042116) | 2.30610361 |
| 166 | complement activation, alternative pathway (GO:0006957) | 2.30029630 |
| 167 | urea metabolic process (GO:0019627) | 2.29274133 |
| 168 | urea cycle (GO:0000050) | 2.29274133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.57461744 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.53115785 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48183460 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35429296 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.17448575 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.94999760 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88941390 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86533558 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83676579 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82605903 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73716499 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.67639749 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66943545 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62815851 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.58495186 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.56046115 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51362385 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50737977 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46879476 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46833156 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46708301 |
| 22 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42125706 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40755304 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29212583 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23821200 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19736765 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09627284 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.07970067 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.07187119 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05192908 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.05105085 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02189221 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02132845 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.00226801 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96109045 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92767537 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.90963847 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88977272 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88561845 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87523603 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84954590 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82088413 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81895356 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81135847 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80881008 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80374752 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75367764 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.75315244 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74411707 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72643691 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71563331 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70770438 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70181439 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69698446 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69428488 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66911634 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64136253 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62978619 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59896300 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56232805 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.51156576 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50169788 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48921436 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46698490 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46694750 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42215590 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41831781 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40275542 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37994651 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37849187 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35319830 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35277828 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35141675 |
| 74 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34964713 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33512438 |
| 76 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33284443 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32813741 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31144787 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31107254 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30397549 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29304439 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29004640 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27491315 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27279597 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26352179 |
| 86 | P68_20966046_ChIP-Seq_HELA_Human | 1.26232819 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26084406 |
| 88 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23751775 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22223205 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21961571 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21421296 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21249615 |
| 93 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.21119216 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20508814 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19718363 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19268535 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 1.19265311 |
| 98 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19084002 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17783065 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16931228 |
| 101 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16138339 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15179011 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14263389 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13670162 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13094021 |
| 106 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12265126 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10659508 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09338490 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09199992 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08483906 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08344918 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08030407 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07877521 |
| 114 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07714623 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07396417 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07172704 |
| 117 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07050695 |
| 118 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06594779 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06198086 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05817907 |
| 121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05031102 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04586393 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04205030 |
| 124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03443726 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02913905 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02770538 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01094953 |
| 128 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97450816 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97085487 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95569219 |
| 131 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94165666 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93726338 |
| 133 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93467178 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93076741 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92833408 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90670484 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89535442 |
| 138 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.88976618 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86566096 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85410582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.40677144 |
| 2 | MP0009840_abnormal_foam_cell | 3.03134491 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.90388442 |
| 4 | MP0005360_urolithiasis | 2.82949255 |
| 5 | MP0003436_decreased_susceptibility_to | 2.75857570 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.75242215 |
| 7 | MP0003303_peritoneal_inflammation | 2.58395447 |
| 8 | MP0000685_abnormal_immune_system | 2.49644038 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.46675815 |
| 10 | MP0001800_abnormal_humoral_immune | 2.37479249 |
| 11 | MP0001790_abnormal_immune_system | 2.36125719 |
| 12 | MP0005387_immune_system_phenotype | 2.36125719 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.34064257 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.32907952 |
| 15 | MP0002419_abnormal_innate_immunity | 2.30416197 |
| 16 | MP0009785_altered_susceptibility_to | 2.22913653 |
| 17 | MP0005025_abnormal_response_to | 2.19884038 |
| 18 | MP0005365_abnormal_bile_salt | 2.19104004 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.18611601 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.17414004 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.13187489 |
| 22 | MP0005671_abnormal_response_to | 2.13053731 |
| 23 | MP0002723_abnormal_immune_serum | 2.04078171 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.03586219 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.93868665 |
| 26 | MP0001819_abnormal_immune_cell | 1.93069491 |
| 27 | MP0008260_abnormal_autophagy | 1.91276996 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.81929279 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 1.80271565 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.77584618 |
| 31 | MP0003724_increased_susceptibility_to | 1.75334007 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.74165305 |
| 33 | MP0001853_heart_inflammation | 1.73959887 |
| 34 | MP0006082_CNS_inflammation | 1.72619192 |
| 35 | MP0002398_abnormal_bone_marrow | 1.72071146 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66905329 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.66636649 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.64997534 |
| 39 | * MP0000716_abnormal_immune_system | 1.64734929 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.63940492 |
| 41 | MP0008469_abnormal_protein_level | 1.59126905 |
| 42 | MP0002405_respiratory_system_inflammati | 1.57440716 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.57125924 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.56715392 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.53089659 |
| 46 | MP0001849_ear_inflammation | 1.50386080 |
| 47 | MP0004947_skin_inflammation | 1.49934951 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.48321835 |
| 49 | MP0004510_myositis | 1.47748995 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.46365533 |
| 51 | MP0009278_abnormal_bone_marrow | 1.45784149 |
| 52 | MP0003252_abnormal_bile_duct | 1.45398379 |
| 53 | MP0004858_abnormal_nervous_system | 1.45111776 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.44942656 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.44667070 |
| 56 | MP0002722_abnormal_immune_system | 1.43020808 |
| 57 | * MP0002429_abnormal_blood_cell | 1.42739385 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.41689185 |
| 59 | MP0000609_abnormal_liver_physiology | 1.41529070 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.40526034 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.40526034 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.38754119 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.38000593 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.37955923 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.36568022 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.35639649 |
| 67 | MP0000343_altered_response_to | 1.34136696 |
| 68 | MP0001873_stomach_inflammation | 1.33949217 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.33709604 |
| 70 | MP0003091_abnormal_cell_migration | 1.22902502 |
| 71 | MP0009764_decreased_sensitivity_to | 1.19078051 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 1.18944799 |
| 73 | MP0008004_abnormal_stomach_pH | 1.13158812 |
| 74 | MP0003866_abnormal_defecation | 1.12919015 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.12771965 |
| 76 | MP0002254_reproductive_system_inflammat | 1.10405417 |
| 77 | MP0002933_joint_inflammation | 1.10057758 |
| 78 | MP0002006_tumorigenesis | 1.08449765 |
| 79 | MP0009763_increased_sensitivity_to | 1.07482932 |
| 80 | MP0003075_altered_response_to | 1.05696575 |
| 81 | MP0005666_abnormal_adipose_tissue | 1.03031062 |
| 82 | MP0000598_abnormal_liver_morphology | 1.00631587 |
| 83 | * MP0002118_abnormal_lipid_homeostasis | 0.98414705 |
| 84 | MP0004130_abnormal_muscle_cell | 0.97844272 |
| 85 | MP0003329_amyloid_beta_deposits | 0.97158403 |
| 86 | MP0005083_abnormal_biliary_tract | 0.97041215 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.96983097 |
| 88 | MP0005451_abnormal_body_composition | 0.96548551 |
| 89 | MP0010234_abnormal_vibrissa_follicle | 0.95475050 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95352912 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.93729607 |
| 92 | MP0005390_skeleton_phenotype | 0.93622855 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.93548055 |
| 94 | MP0000604_amyloidosis | 0.92831434 |
| 95 | MP0004233_abnormal_muscle_weight | 0.91093452 |
| 96 | MP0000249_abnormal_blood_vessel | 0.90984625 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.90681590 |
| 98 | MP0005164_abnormal_response_to | 0.89270043 |
| 99 | MP0004381_abnormal_hair_follicle | 0.89108377 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.88313842 |
| 101 | MP0005409_darkened_coat_color | 0.88119245 |
| 102 | MP0006054_spinal_hemorrhage | 0.87672034 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.87416739 |
| 104 | MP0003828_pulmonary_edema | 0.86759842 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.86558314 |
| 106 | MP0000490_abnormal_crypts_of | 0.86455430 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.86426813 |
| 108 | MP0005310_abnormal_salivary_gland | 0.84432767 |
| 109 | MP0003448_altered_tumor_morphology | 0.82174657 |
| 110 | MP0005166_decreased_susceptibility_to | 0.81965219 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.81956666 |
| 112 | MP0005332_abnormal_amino_acid | 0.79916439 |
| 113 | MP0000747_muscle_weakness | 0.78074061 |
| 114 | MP0003795_abnormal_bone_structure | 0.77927267 |
| 115 | MP0000858_altered_metastatic_potential | 0.76770063 |
| 116 | MP0005670_abnormal_white_adipose | 0.73432423 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.73131722 |
| 118 | MP0002971_abnormal_brown_adipose | 0.71944131 |
| 119 | MP0005165_increased_susceptibility_to | 0.70762910 |
| 120 | MP0000371_diluted_coat_color | 0.70462647 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.69700204 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.69416801 |
| 123 | MP0004883_abnormal_blood_vessel | 0.69187418 |
| 124 | MP0004264_abnormal_extraembryonic_tissu | 0.68994597 |
| 125 | MP0005023_abnormal_wound_healing | 0.68684512 |
| 126 | MP0001851_eye_inflammation | 0.68666263 |
| 127 | MP0001663_abnormal_digestive_system | 0.68664949 |
| 128 | MP0003690_abnormal_glial_cell | 0.68121302 |
| 129 | MP0003186_abnormal_redox_activity | 0.66443709 |
| 130 | MP0003279_aneurysm | 0.64697337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.65077068 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.36067227 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.11399702 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.86032369 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.77203422 |
| 6 | Recurrent viral infections (HP:0004429) | 3.57114326 |
| 7 | Cellulitis (HP:0100658) | 3.38577484 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.38086166 |
| 9 | Myositis (HP:0100614) | 3.32667776 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.30452116 |
| 11 | Chronic otitis media (HP:0000389) | 3.27595486 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.24414764 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 3.20324722 |
| 14 | Colitis (HP:0002583) | 3.13388677 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.11291024 |
| 16 | Nuclear cataract (HP:0100018) | 3.11256567 |
| 17 | Recurrent skin infections (HP:0001581) | 3.08121365 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.05310969 |
| 19 | Joint hemorrhage (HP:0005261) | 3.05217561 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.02661794 |
| 21 | * Loss of speech (HP:0002371) | 3.02661402 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.98675209 |
| 23 | IgM deficiency (HP:0002850) | 2.98202964 |
| 24 | Meningitis (HP:0001287) | 2.93870354 |
| 25 | Inflammation of the large intestine (HP:0002037) | 2.92537565 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91615948 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.90275542 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 2.87762070 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.85652063 |
| 30 | Abnormal platelet function (HP:0011869) | 2.83563655 |
| 31 | Impaired platelet aggregation (HP:0003540) | 2.83563655 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83516468 |
| 33 | Thrombocytosis (HP:0001894) | 2.77937131 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.77076181 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77076181 |
| 36 | Glomerulonephritis (HP:0000099) | 2.74750691 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.72095357 |
| 38 | Deep venous thrombosis (HP:0002625) | 2.69044195 |
| 39 | Complement deficiency (HP:0004431) | 2.66801896 |
| 40 | Xanthomatosis (HP:0000991) | 2.60199375 |
| 41 | Purpura (HP:0000979) | 2.59374489 |
| 42 | Epistaxis (HP:0000421) | 2.58299567 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57454371 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57454371 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57454371 |
| 46 | Thin bony cortex (HP:0002753) | 2.57274985 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.57023043 |
| 48 | Amyloidosis (HP:0011034) | 2.53647045 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.52930795 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.52676203 |
| 51 | Periodontitis (HP:0000704) | 2.52604884 |
| 52 | Pustule (HP:0200039) | 2.52572809 |
| 53 | Disinhibition (HP:0000734) | 2.50438203 |
| 54 | Gingival bleeding (HP:0000225) | 2.50227335 |
| 55 | Orchitis (HP:0100796) | 2.50192238 |
| 56 | Vasculitis (HP:0002633) | 2.49080015 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.49012816 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.48794365 |
| 59 | Gingivitis (HP:0000230) | 2.48061249 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.42630987 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.42476573 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.41039194 |
| 63 | Myocardial infarction (HP:0001658) | 2.40612198 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39700096 |
| 65 | Abnormality of the nasal mucosa (HP:0000433) | 2.39060235 |
| 66 | Petechiae (HP:0000967) | 2.38335477 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.33748649 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.33521924 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33028565 |
| 70 | Obstructive lung disease (HP:0006536) | 2.33028565 |
| 71 | Abnormality of complement system (HP:0005339) | 2.31914460 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.30639789 |
| 73 | Optic neuritis (HP:0100653) | 2.30639789 |
| 74 | Nasal polyposis (HP:0100582) | 2.30407261 |
| 75 | Pathologic fracture (HP:0002756) | 2.30281903 |
| 76 | Thoracic kyphosis (HP:0002942) | 2.27321960 |
| 77 | Osteomyelitis (HP:0002754) | 2.26040883 |
| 78 | Upper motor neuron abnormality (HP:0002127) | 2.24706897 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.23911168 |
| 80 | Arterial thrombosis (HP:0004420) | 2.23764081 |
| 81 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22420175 |
| 82 | Achilles tendon contracture (HP:0001771) | 2.22251488 |
| 83 | Chest pain (HP:0100749) | 2.20718180 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 2.18800592 |
| 85 | Abnormality of T cells (HP:0002843) | 2.18602472 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.18419651 |
| 87 | Bone pain (HP:0002653) | 2.17309571 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17216582 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17216582 |
| 90 | Malnutrition (HP:0004395) | 2.16136094 |
| 91 | Hypercholesterolemia (HP:0003124) | 2.15026365 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.15026160 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14574407 |
| 94 | Increased connective tissue (HP:0009025) | 2.14168331 |
| 95 | Hypobetalipoproteinemia (HP:0003563) | 2.12578633 |
| 96 | Progressive neurologic deterioration (HP:0002344) | 2.11270060 |
| 97 | Prolonged partial thromboplastin time (HP:0003645) | 2.09681271 |
| 98 | Granulocytopenia (HP:0001913) | 2.09421792 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 2.08661401 |
| 100 | Verrucae (HP:0200043) | 2.08547821 |
| 101 | Papilloma (HP:0012740) | 2.08547821 |
| 102 | Prolonged neonatal jaundice (HP:0006579) | 2.08472224 |
| 103 | Encephalitis (HP:0002383) | 2.08373157 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.08246135 |
| 105 | Mitral stenosis (HP:0001718) | 2.06621383 |
| 106 | Leukocytosis (HP:0001974) | 2.05762352 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 2.05499612 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05250026 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05250026 |
| 110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05250026 |
| 111 | Cervical subluxation (HP:0003308) | 2.05024700 |
| 112 | Hematochezia (HP:0002573) | 2.04667704 |
| 113 | Axonal loss (HP:0003447) | 2.04635230 |
| 114 | Urticaria (HP:0001025) | 2.04622747 |
| 115 | Abnormal platelet volume (HP:0011876) | 2.03744361 |
| 116 | Distal lower limb amyotrophy (HP:0008944) | 2.03258449 |
| 117 | Hypoglycemic coma (HP:0001325) | 2.03218980 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 2.02803927 |
| 119 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02324181 |
| 120 | Menorrhagia (HP:0000132) | 2.01418639 |
| 121 | Eosinophilia (HP:0001880) | 2.01341904 |
| 122 | Thyroiditis (HP:0100646) | 2.01083212 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.99853291 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99517391 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.98826937 |
| 126 | Pulmonary embolism (HP:0002204) | 1.97046174 |
| 127 | Chronic diarrhea (HP:0002028) | 1.95624372 |
| 128 | Increased IgE level (HP:0003212) | 1.95252874 |
| 129 | Apathy (HP:0000741) | 1.94913511 |
| 130 | Lymphopenia (HP:0001888) | 1.94557048 |
| 131 | Increased serum ferritin (HP:0003281) | 1.93152161 |
| 132 | Diminished motivation (HP:0000745) | 1.91363886 |
| 133 | Broad face (HP:0000283) | 1.89675028 |
| 134 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88846376 |
| 135 | Abnormality of the thoracic spine (HP:0100711) | 1.88202454 |
| 136 | Protrusio acetabuli (HP:0003179) | 1.85878075 |
| 137 | Mutism (HP:0002300) | 1.85332146 |
| 138 | Stomatitis (HP:0010280) | 1.83631504 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.83543925 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.80715481 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.80715481 |
| 142 | Esophageal varix (HP:0002040) | 1.78020755 |
| 143 | Joint stiffness (HP:0001387) | 1.76325671 |
| 144 | Cardiomegaly (HP:0001640) | 1.74074922 |
| 145 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73359473 |
| 146 | Spondylolisthesis (HP:0003302) | 1.73291350 |
| 147 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.72470705 |
| 148 | Hyperacusis (HP:0010780) | 1.72009669 |
| 149 | Hypophosphatemia (HP:0002148) | 1.71187534 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.66875929 |
| 151 | Pulmonary infiltrates (HP:0002113) | 1.66319829 |
| 152 | Peripheral demyelination (HP:0011096) | 1.66253335 |
| 153 | Flat acetabular roof (HP:0003180) | 1.64727295 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.63898007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.13430485 |
| 2 | EEF2K | 3.68528653 |
| 3 | ERN1 | 3.66409580 |
| 4 | NME2 | 2.86945059 |
| 5 | PRPF4B | 2.60921275 |
| 6 | KIT | 2.37406760 |
| 7 | MAP3K10 | 2.35711666 |
| 8 | TYK2 | 2.30667943 |
| 9 | TAOK2 | 2.21668524 |
| 10 | CSF1R | 2.21126576 |
| 11 | TRIB3 | 2.20678644 |
| 12 | PKN2 | 2.17323340 |
| 13 | ICK | 2.16337952 |
| 14 | BLK | 2.16229637 |
| 15 | TGFBR2 | 2.14872015 |
| 16 | IRAK4 | 2.14007960 |
| 17 | MAP2K3 | 2.13283282 |
| 18 | TBK1 | 2.10024103 |
| 19 | BTK | 2.00873016 |
| 20 | ZAP70 | 1.91317621 |
| 21 | IRAK3 | 1.89014349 |
| 22 | TAOK3 | 1.87352381 |
| 23 | MAP3K14 | 1.73977902 |
| 24 | DDR2 | 1.73408535 |
| 25 | EPHB1 | 1.69042721 |
| 26 | TAOK1 | 1.68855636 |
| 27 | SMG1 | 1.68800010 |
| 28 | FLT3 | 1.66698765 |
| 29 | MAPKAPK3 | 1.64824687 |
| 30 | STK10 | 1.63192897 |
| 31 | JAK3 | 1.58748608 |
| 32 | SYK | 1.56200787 |
| 33 | GRK6 | 1.54912126 |
| 34 | TEC | 1.53377684 |
| 35 | FGFR4 | 1.45453701 |
| 36 | TESK2 | 1.44794129 |
| 37 | TRPM7 | 1.44759502 |
| 38 | JAK1 | 1.42765096 |
| 39 | SIK1 | 1.42631054 |
| 40 | IKBKE | 1.38902858 |
| 41 | CSK | 1.37520598 |
| 42 | MAP3K13 | 1.36931209 |
| 43 | EPHA2 | 1.35364171 |
| 44 | MST1R | 1.34070980 |
| 45 | CDC42BPA | 1.33826769 |
| 46 | IKBKB | 1.32140251 |
| 47 | TTN | 1.31647258 |
| 48 | FGR | 1.26721068 |
| 49 | TESK1 | 1.25483467 |
| 50 | MAP3K1 | 1.24481773 |
| 51 | ITK | 1.22315075 |
| 52 | IRAK2 | 1.19106303 |
| 53 | PTK6 | 1.19058348 |
| 54 | TXK | 1.16841556 |
| 55 | HCK | 1.15149632 |
| 56 | BCKDK | 1.12398696 |
| 57 | FES | 1.12385041 |
| 58 | LRRK2 | 1.12093197 |
| 59 | GRK7 | 1.09141041 |
| 60 | RPS6KA4 | 0.98483389 |
| 61 | PIK3CG | 0.97351424 |
| 62 | LCK | 0.96455657 |
| 63 | RIPK4 | 0.95971868 |
| 64 | MATK | 0.95970132 |
| 65 | RIPK1 | 0.95143011 |
| 66 | PRKD2 | 0.94852063 |
| 67 | MOS | 0.94310228 |
| 68 | LYN | 0.93207491 |
| 69 | TNK2 | 0.92004539 |
| 70 | PDGFRA | 0.91300121 |
| 71 | PDPK1 | 0.90979080 |
| 72 | CLK1 | 0.89977256 |
| 73 | JAK2 | 0.86253122 |
| 74 | MAPK11 | 0.85125720 |
| 75 | CAMK1D | 0.82004348 |
| 76 | CHUK | 0.80301875 |
| 77 | KDR | 0.80046543 |
| 78 | PIM1 | 0.79444693 |
| 79 | RPS6KB2 | 0.79142118 |
| 80 | ABL2 | 0.75336833 |
| 81 | TGFBR1 | 0.74791877 |
| 82 | MARK2 | 0.73267014 |
| 83 | LMTK2 | 0.72711482 |
| 84 | MAP3K7 | 0.70517059 |
| 85 | STK4 | 0.69964173 |
| 86 | PRKG2 | 0.67271929 |
| 87 | PAK4 | 0.66165068 |
| 88 | MAPK12 | 0.66080060 |
| 89 | CDK4 | 0.64337512 |
| 90 | BMX | 0.63275648 |
| 91 | NEK9 | 0.61830461 |
| 92 | TIE1 | 0.61679618 |
| 93 | MAP3K3 | 0.61056806 |
| 94 | PRKAA2 | 0.60663384 |
| 95 | MAPK4 | 0.59701721 |
| 96 | HIPK2 | 0.59306066 |
| 97 | PRKD3 | 0.59000849 |
| 98 | MTOR | 0.58009291 |
| 99 | ARAF | 0.57525126 |
| 100 | FGFR3 | 0.57389784 |
| 101 | MAP3K11 | 0.57000770 |
| 102 | IRAK1 | 0.56004530 |
| 103 | SIK2 | 0.55522661 |
| 104 | RPS6KA6 | 0.54955792 |
| 105 | CAMK1G | 0.51840941 |
| 106 | NLK | 0.51819478 |
| 107 | KSR2 | 0.51472031 |
| 108 | MAP2K2 | 0.50386851 |
| 109 | MAP2K6 | 0.47260623 |
| 110 | PTK2 | 0.46986215 |
| 111 | RPS6KC1 | 0.46654291 |
| 112 | RPS6KL1 | 0.46654291 |
| 113 | MAPK7 | 0.46438002 |
| 114 | SCYL2 | 0.46393779 |
| 115 | MAPKAPK2 | 0.45691165 |
| 116 | DMPK | 0.44509653 |
| 117 | TYRO3 | 0.43405656 |
| 118 | CDK6 | 0.42120935 |
| 119 | MARK3 | 0.42023464 |
| 120 | PRKCQ | 0.39973088 |
| 121 | MAPKAPK5 | 0.39415272 |
| 122 | MAP3K6 | 0.38479328 |
| 123 | PDK2 | 0.38077483 |
| 124 | STK24 | 0.37958791 |
| 125 | RPS6KA2 | 0.37618005 |
| 126 | PRKCH | 0.36387077 |
| 127 | PIM2 | 0.36009558 |
| 128 | CDK12 | 0.34984431 |
| 129 | ABL1 | 0.31456670 |
| 130 | EPHA3 | 0.31373203 |
| 131 | PDK1 | 0.30806702 |
| 132 | PRKCD | 0.29835231 |
| 133 | MAP3K8 | 0.29604054 |
| 134 | EGFR | 0.29498636 |
| 135 | MYLK | 0.28888189 |
| 136 | SIK3 | 0.28532469 |
| 137 | DYRK1B | 0.28173066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02450711 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.60688227 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37622608 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29032845 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28652412 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20166695 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.17938994 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97537417 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.96378871 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92446580 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88214653 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83459217 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.79602216 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70545932 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60328406 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59152456 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54174782 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.51605644 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49939152 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42525159 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42428450 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41167065 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.40891183 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.40259259 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.39496617 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.38922385 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.38083448 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34403637 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.32753970 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32495604 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29398995 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.27029350 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25831829 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22888459 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.20734312 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.19968422 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19066677 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17830984 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17519777 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15868374 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15745476 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15466051 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14321990 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14235777 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12420450 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11929096 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.10431213 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09213685 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09031351 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08909079 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.08459687 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08290412 |
| 53 | * ABC transporters_Homo sapiens_hsa02010 | 1.04444806 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04127299 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02129827 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.01911808 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 1.01820353 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01145815 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00779657 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98884244 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98711592 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98703815 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97210344 |
| 64 | * Peroxisome_Homo sapiens_hsa04146 | 0.97195598 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96941360 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.96568361 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.95797462 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95422100 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.94191663 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93953485 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93802503 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92801931 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92371663 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91794283 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90021735 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89164745 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.88560951 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.87247987 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83825119 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81140490 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80976642 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79227032 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79090148 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78621685 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.78515748 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78211392 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78070641 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75740554 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74212763 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74124088 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73568555 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73380923 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72889655 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71372931 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70982712 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.68484519 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.68095116 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67018380 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66866152 |
| 100 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66482062 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65839184 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64809784 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64403295 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63803905 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63620218 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63422402 |
| 107 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61990755 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60397911 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60160009 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59662119 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.59434281 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57000574 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.55724229 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55032355 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53508794 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52773947 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52712900 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51805029 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51721817 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49724780 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49039952 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48584028 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47511500 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47402980 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.47402882 |
| 126 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47345179 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47215736 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47158786 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47054375 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46891274 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46528667 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45987075 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45954683 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45441894 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45207813 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44388484 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43013487 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.42740272 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40530480 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40025645 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39498378 |

